Examining the Impact of Resilience Strategies in Mitigating Medicine Shortages in the United Kingdom's (UK) Pharmaceutical Supply Chain (PSC)

Emilia Vann Yaroson, Liz Breen, Jiachen Hou, Julie Sowter

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: Medicine shortages have a detrimental impact on stakeholders in the PSC. Existing studies suggest that building resilience strategies can mitigate the effects of these shortages. As such, this research examined if resilience strategies can reduce the impact of medicine shortages in the United Kingdom's (UK) pharmaceutical supply chain (PSC).

Methodology: A sequential mixed-methods approach that involved qualitative and quantitative research enquiry was employed in this study. The data were collected using semi-structured interviews with 23 key UK PSC actors at the qualitative stage. During the quantitative phase, 106 respondents completed the survey questionnaires. The data were analysed using partial least square structural equation modelling (PLS-SEM).

Findings: The results revealed that reactive and proactive elements of resilience strategies helped tackle medicine shortages. Reactive strategies increased relational issues such as behavioural uncertainty, while proactive strategies mitigated them.

Practical implications: The findings suggest that PSC managers and decision-makers can benefit from adopting structural flexibility and proactive strategies, which are cost-effective measures to tackle medicine shortages. Also, engaging in strategic alliances as a proactive strategy mitigates relational issues that may arise in a complex SC.

Originality: This study is the first to provide empirical evidence of the impact of resilience strategies in mitigating medicine shortages in the UK's PSC.
Original languageEnglish
JournalBenchmarking
Publication statusAccepted/In press - 5 Feb 2023

Fingerprint

Dive into the research topics of 'Examining the Impact of Resilience Strategies in Mitigating Medicine Shortages in the United Kingdom's (UK) Pharmaceutical Supply Chain (PSC)'. Together they form a unique fingerprint.

Cite this